SCHEMBL14082172

SCHEMBL14082172

O=C(CNc1cccc2ncccc12)N/N=C/c1cc(Br)c(O)c(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.53
▸ KDM4E B2RXH2 4/20 0.53
▸ MCL1 Q07820 1/20 0.48
▸ MEN1 O00255 8/20 0.47
▸ KMT2A Q03164 8/20 0.47
▸ GRK2 P25098 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ ROCK2 O75116 1/20 0.45
▸ LMNA P02545 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ POLB P06746 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CHEK1 O14757 1/20 0.43
▸ AURKA O14965 1/20 0.43
▸ DAPK3 O43293 1/20 0.43
▸ JAK2 O60674 1/20 0.43
▸ PRKD3 O94806 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12872564 0.91 MAPT (0.52) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL12648547 0.88 SIRT1 (0.56) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL12648526 0.84 MAPT (0.66) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL14082245 0.84 MAPT (0.48) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL3633243 0.78 ROCK2 (0.55) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL3633246 0.78 ROCK2 (0.55) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL1672426 0.78 ROCK2 (0.66) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL1672427 0.78 ROCK2 (0.66) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL14082221 0.75 MAPT (0.66) MAPTKDM4EMCL1MEN1KMT2A
SCHEMBL12648540 0.74 MAPT (0.67) MAPTKDM4EMCL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
Send feedback